Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in mild allergic asthma
NCT04035109Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2019
- Primary completion
- Oct 2022
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of anakinra in allergic asthma, sponsored by University of North Carolina at Chapel Hill. Planned start Dec 2019; status: withdrawn.
02
Drugs
anakinra
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT04035109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035109.